TargImmune Therapeutics AG

TargImmune Therapeutics AG is a startup company established in March 2016 in Basel, Switzerland. TargImmune is developing a novel cancer-targeted platform technology CTPIC in the field of immuno-oncology and personalized therapy.

News

News

TargImmune Therapeutics gets acquired

iOncologi, a Florida-based clinical-stage company focused on advancing immunotherapy platform technologies, has acquired TargImmune Therapeutics.

Building F
Industry Biotech
Research Topics Oncology
Employees 9
Founding year 2016